2018-10-10T09:42:40-05:00 2017-12-31 521511275 RAFFA PC 1899 L STREET NW SUITE 850 WASHINGTON DC 20036 990 2017-01-01 320020119 ASTS FOUNDATION ASTS 7034147870 2461 SOUTH CLARK STREET NO 640 ARLINGTON VA 22202 KIMBERLY A GIFFORD MBA EXECUTIVE DIRECTOR 7034147870 2018-10-10 1 FRANK H SMITH P00639053 2028825000 2018-10-10 207.238.152.241 2018-10-10 10:42:33 ED P D653353D7DBCB53E6E80CBBAE88F302164E361EF B28EB3D1A33359A1C7D8444A7227EB34E855D8C5 2017 2018-06-14 16:35:46Z KIMBERLY A GIFFORD MBA 2461 SOUTH CLARK STREET NO 640 ARLINGTON VA 22202 5345179 0 X WWW.ASTS.ORG/ABOUT-ASTS/ASTS-FOUNDATION X 2002 VA CONDUCTS EDUCATIONAL AND RESEARCH PROGRAMS RELATING TO ORGAN TRANSPLANTATION. 15 15 9 90 0 0 724546 670369 0 0 576541 1255237 0 12328 1301087 1937934 294031 441328 0 0 74931 66722 0 0 54130 190708 199742 559670 707792 741417 1230142 17286912 18789864 142589 92683 17144323 18697181 X THE FOUNDATION OF THE AMERICAN SOCIETY OF TRANSPLANT SURGEONS (THE FOUNDATION) PROVIDES ADDITIONAL PROGRAMS THAT SUPPORT THE MISSION AND ASSURE THE FUTURE OF THE AMERICAN SOCIETY OF TRANSPLANT SURGEONS (THE SOCIETY). THE MISSION OF THE THE SOCIETY IS TO ADVANCE THE ART AND SCIENCE OF TRANSPLANT SURGERY THROUGH LEADERSHIP, ADVOCACY, EDUCATION AND TRAINING. THE SOCIETY ACHIEVES ITS MISSION THROUGH FOUR STRATEGIC GOALS: ADVOCACY, RESEARCH, TRAINING AND PROFESSIONAL DEVELOPMENT AND OPTIMAL PATIENT CARE. THE ACTIVITIES OF THE FOUNDATION SUPPORT THESE GOALS AND STRIVE TO POSITIVELY IMPACT THE MEMBERSHIP AND THE PATIENTS THEY SERVE. 0 0 471282 441328 THE FOUNDATION, THROUGH STRATEGIC PARTNERSHIPS, PROVIDES FUNDING FOR RESEARCH GRANTS DESIGNED TO ADVANCE THE FIELD OF ORGAN TRANSPLANTATION. RESEARCH GRANTS ARE AVAILABLE TO THE SOCIETY'S MEMBERS AND THEIR TRAINEES THROUGHOUT THE UNITED STATES AND CANADA. SINCE THE PROGRAM'S INCEPTION, OVER 200 PEOPLE HAVE RECEIVED MORE THAN $10M IN RESEARCH GRANT FUNDING. 471282 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 4 0 1 9 1 0 0 0 0 0 0 0 0 0 0 X 15 15 0 0 0 0 0 1 0 1 1 0 0 1 1 1 1 1 1 0 0 0 AL AK CA CO AZ DE FL GA IL KS KY ME CT OR VA OK PA RI TN UT TX WA WV WI MA MD MN MI MS MO NJ NM NY NC ND OH SC X KIMBERLY A GIFFORD MBA 7034147870 2461 SOUTH CLARK STREET NO 640 ARLINGTON VA 22202 CHARLES M MILLER MD PRES UNTIL 05/2017, IMM. PAST PRESIDENT 0.50 3.00 X X 0 0 0 TIMOTHY L PRUETT MD VICE PRESIDENT - UNTIL 05/2017, PRES. 1.00 5.00 X X 0 0 0 LLOYD E RATNER MD MPH SECRETARY/TREASURER 0.50 1.00 X X 0 0 0 PETER G STOCK MD PHD IMM. PAST PRESIDENT - UNTIL 05/2017 0.50 1.00 X X 0 0 0 PETER L ABT MD DIRECTOR 0.50 0.50 X 0 0 0 TALIA B BARKER DIRECTOR 0.50 0.50 X 0 0 0 GINNY L BUMGARDNER MD PHD DIRECTOR - UNTIL 05/2017 0.50 0.50 X 0 0 0 WILLIAM C CHAPMAN MD DIRECTOR 0.50 0.50 X 0 0 0 KENNETH D CHAVIN MD PHD DIRECTOR - UNTIL 05/2017 0.50 0.50 X 0 0 0 JEAN C EMOND MD DIRECTOR 0.50 0.50 X 0 0 0 CARLOS O ESQUIVEL MD PHD DIRECTOR 0.50 0.50 X 0 0 0 JONATHAN P FRYER DIRECTOR 0.50 0.50 X 0 0 0 A OSAMA GABER MD FACS DIRECTOR 0.50 0.50 X 0 0 0 WENDY J GRANT MD DIRECTOR 0.50 0.50 X 0 0 0 DIXON B KAUFMAN MD PHD DIRECTOR 0.50 0.50 X 0 0 0 ALAN I REED MD MBA DIRECTOR 0.50 0.50 X 0 0 0 DORRY L SEGEV MD PHD DIRECTOR 0.50 0.50 X 0 0 0 RANDALL S SUNG MD DIRECTOR 0.50 0.50 X 0 0 0 KIMBERLY A GIFFORD MBA EXECUTIVE DIRECTOR 2.00 38.00 X 14955 220546 23379 LAUREL KULIKOSKY DEPUTY DIRECTOR 2.00 38.00 X 310 134547 9840 15265 355093 33219 0 0 1 0 0 154934 137861 377574 670369 609733 609733 4052749 3407245 645504 645504 645504 MISCELLANEOUS INCOME 900099 12328 12328 12328 1937934 0 0 1267565 441328 441328 16438 9862 4933 1643 38057 9069 15815 13173 2511 670 1020 821 5912 1811 2328 1773 3804 1295 1457 1052 2946 40 2873 33 10536 1177 8401 958 7541 12 13 7516 142512 1144 140055 1313 4436 1171 1318 1947 7263 2472 2782 2009 8863 56 63 8744 2120 722 812 586 1232 419 472 341 STATE FILINGS 12192 12192 MISCELLANEOUS 71 24 27 20 DUES AND SUBSCRIPTIONS 30 10 11 9 707792 471282 182380 54130 1585150 1216213 191798 181402 15442150 17324028 67814 68221 17286912 18789864 89 183 142500 92500 142589 92683 X 16314869 17857450 829454 839731 17144323 18697181 17286912 18789864 X 1230142 166327 156389 X 0 1 X 1 0 X X 1 ASTS 133048373 7 1 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 X PART X, LINE 2: THE FOUNDATION BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR ANY TAX POSITIONS TAKEN, AND THEREFORE DID NOT IDENTIFY ANY MATERIAL UNCERTAIN TAX POSITIONS. 1 ASTS PRESIDENTIAL STUDENT MENTOR GRANT 4 21500 ASTS FELLOWSHIP IN TRANSPLANTATION GRANT 2 127500 ASTS FACULTY DEVELOPMENT GRANT 2 212328 ASTS RESIDENT SCIENTIST SCHOLARSHIP 2 80000 PART I, LINE 2: GRANTS ARE AWARDED BASED ON A COMPETITIVE REVIEW BY THE FOUNDATION'S LEADERSHIP, GRANTS REVIEW COMMITTEE MEMBERS AND MEMBERS-AT-LARGE. A BUDGET IS REQUIRED FOR EACH GRANT APPLICATION AND ANY VARIANCE FROM THE SUBMITTED BUDGET REQUIRES APPROVAL OF THE GRANTS REVIEW COMMITTEE. FOR GRANTS $10,000 OR GREATER, CHECKS ARE ISSUED TO THE INSTITUTION, OFTEN IN TWO INSTALLMENTS. PRIOR TO DISPERSING THE SECOND INSTALLMENT, A PROGRESS REPORT IS DUE TO THE FOUNDATION. ANY CONCERNS ARE ADDRESSED PRIOR TO ISSUING THE REMAINING FUNDS. GRANTS OF LESS THAN $10,000 ARE TYPICALLY PAID AS A SINGLE PAYMENT. 0 0 0 0 0 0 0 1 0 KIMBERLY A GIFFORD MBA EXECUTIVE DIRECTOR 14288 210713 667 9833 0 0 714 10536 770 11359 16439 242441 0 0 PART I, LINE 3 THE FOUNDATION DOES NOT DIRECTLY HIRE OR COMPENSATE EMPLOYEES. ALL EMPLOYEES ARE EMPLOYEES OF THE SOCIETY, A RELATED ORGANIZATION. THE COST OF THE SOCIETY'S OFFICER AND HIGHLY COMPENSATED EMPLOYEES ARE ALLOCATED UNDER THE TERMS OF A COST SHARING AGREEMENT. THE SOCIETY'S COMPENSATION COMMITTEE CONSISTING OF OFFICERS OF THE EXECUTIVE COMMITTEE CONDUCTS AN ANNUAL REVIEW WITH INPUT FROM COMMITTEE CHAIRS AND COUNCIL MEMBERS. THE SOCIETY'S COMPENSATION COMMITTEE ANALYZES RELEVANT BENCHMARK DATA, REVIEWS THE EVALUATIONS AND MAKES RECOMMENDATIONS TO THE SOCIETY'S COUNCIL/BOARD FOR LEVEL OF COMPENSATION. PART I, LINE 7 LAUREL KULIKOSKY, DEPUTY DIRECTOR, AND KIMBERLY A. GIFFORD, MBA, EXECUTIVE DIRECTOR, RECEIVED A BONUS WHICH WAS AWARDED BASED ON AN EVALUATION OF THEIR RESPECTIVE PERFORMANCES. FORM 990, PART VI, SECTION A, LINE 7A THE AFFILIATED ORGANIZATION, THE SOCIETY, HAS MEMBERS THAT ELECT THE GOVERNING BODY WHICH SERVES BOTH THE SOCIETY AND THE FOUNDATION. FORM 990, PART VI, SECTION B, LINE 11B THE FEDERAL FORM 990 IS PREPARED BY AN INDEPENDENT ACCOUNTANT AND UPON SUBMISSION OF THE DRAFT, IS REVIEWED BY THE SECRETARY/TREASURER AND EXECUTIVE DIRECTOR. THE FORM 990 IS PRESENTED TO THE BOARD OF DIRECTORS FOR REVIEW AND DISCUSSION PRIOR TO FINALIZING WITH THE INTERNAL REVENUE SERVICE. FORMAL APPROVAL IS RECORDED IN THE MINUTES. FORM 990, PART VI, SECTION B, LINE 12C TO ENSURE ACCURATE, UP TO DATE INFORMATION, EACH BOARD MEMBER REVIEWS HIS OR HER DISCLOSURE STATEMENT DURING FACE-TO-FACE MEETINGS AND UPDATES AS NECESSARY BETWEEN MEETINGS. EACH BOARD MEMBER CLEARLY DESCRIBES HIS OR HER INTEREST IN EACH SUCH ISSUE, SUBJECT, PERSON OR ENTITY ON THIS FORM AND RETURN TO THE FOUNDATION'S EXECUTIVE DIRECTOR. THE INFORMATION ON THIS FORM IS REVIEWED BY THE PRESIDENT AND EXECUTIVE DIRECTOR, AND SHARED WITH THE BOARD OF DIRECTORS IF RELEVANT TO THE DISCUSSION AT HAND. THE BOARD MEMBER MAY VOLUNTARILY RECUSE HIM/HERSELF FROM DISCUSSION AND/OR VOTING ON THE BASIS OF A CONFLICT OF INTEREST. IN ADDITION, THE BOARD OF DIRECTORS MAY REQUIRE THAT THE FOUDATION'S MEMBER: (A) REFRAIN FROM VOTING ON THE ISSUE, (B) NOT PARTICIPATE IN EITHER THE DISCUSSION OR THE VOTE ON THE ISSUE, (C) LEAVE THE ROOM DURING DISCUSSION AND VOTING ON THE ISSUE, OR (D) EXPLAIN HIS OR HER INTEREST IN THE MATTER FULLY SO THE BOARD OF DIRECTORS MAY WEIGH THE BOARD MEMBERS FURTHER PARTICIPATION. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE ON THE PUBLIC PORTION OF THE WEBSITE. FINANCIAL STATEMENTS ARE PROVIDED UPON REQUEST. FORM 990, PART XI, LINE 9: REVERSAL OF PARTIALLY PAID GRANTS 156,389. AMERICAN SOCIETY OF TRANSPLANT SURGEONS 2461 SOUTH CLARK STREET SUITE 640 ARLINGTON VA 22202 133048373 PROMOTE EDUCATION, TRAINING & RESEARCH IN ORGAN & CELLULAR TRANSPLANTATION. OR 501(C)(3) LINE 7 N/A 0 0 0 1 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0